APO Research

APO RESEARCH · REPORT

Enzyme-Linked Immunosorbent Assay (ELISA) Service

Selected research

Industry Research

Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Research Report 2026

Market perspective

The global Enzyme-Linked Immunosorbent Assay (ELISA) Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Enzyme-Linked Immunosorbent Assay (ELISA) Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Enzyme-Linked Immunosorbent Assay (ELISA) Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Enzyme-Linked Immunosorbent Assay (ELISA) Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Enzyme-Linked Immunosorbent Assay (ELISA) Service include Virology Research Services Ltd, ACROBiosystems, Boster Bio, RayBiotech, Inc, Precision Medicine Group, LLC, Bio-Techne, Cellular Technology Limited(immunospot), Sino Biological, Inc and R&D Systems, Inc, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Enzyme-Linked Immunosorbent Assay (ELISA) Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Enzyme-Linked Immunosorbent Assay (ELISA) Service.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Enzyme-Linked Immunosorbent Assay (ELISA) Service Market by Company

Virology Research Services Ltd

ACROBiosystems

Boster Bio

RayBiotech, Inc

Precision Medicine Group, LLC

Bio-Techne

Cellular Technology Limited(immunospot)

Sino Biological, Inc

R&D Systems, Inc

ProteoGenix

Eve Technologies

NorthEast BioAnalytical Laboratories LLC

mabtech

Pestka Biomedical Laboratories, Inc

Thermo Fisher Scientific

Antibodies Incorporated

Kaneka Eurogentec S.A

Enzyme-Linked Immunosorbent Assay (ELISA) Service Segment by Type

Routine ELISA Assays

Targeted Assay Development

Enzyme-Linked Immunosorbent Assay (ELISA) Service Segment by Application

Disease Diagnosis

Vaccine Effectiveness Evaluation

Drug Development

Allergen Testing

Others

Enzyme-Linked Immunosorbent Assay (ELISA) Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enzyme-Linked Immunosorbent Assay (ELISA) Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enzyme-Linked Immunosorbent Assay (ELISA) Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enzyme-Linked Immunosorbent Assay (ELISA) Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Enzyme-Linked Immunosorbent Assay (ELISA) Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Market Share by Type (2021-2026) Table 7. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Market Share by Type (2027-2032) Table 9. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Market Share by Application (2021-2026) Table 11. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Market Share by Application (2027-2032) Table 13. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Share by Region (2021-2026) Table 16. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Share by Region (2027-2032) Table 18. Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Trends Table 19. Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Drivers Table 20. Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Opportunities and Challenges Table 21. Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Restraints Table 22. Global Top Enzyme-Linked Immunosorbent Assay (ELISA) Service Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Market Share by Players (2021-2026) Table 24. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Enzyme-Linked Immunosorbent Assay (ELISA) Service, Headquarters and Area Served Table 26. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Country (2027-2032) & (US$ Million) Table 45. Virology Research Services Ltd Company Information Table 46. Virology Research Services Ltd Business Overview Table 47. Virology Research Services Ltd Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) & (US$ Million) Table 48. Virology Research Services Ltd Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 49. Virology Research Services Ltd Recent Developments Table 50. ACROBiosystems Company Information Table 51. ACROBiosystems Business Overview Table 52. ACROBiosystems Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) & (US$ Million) Table 53. ACROBiosystems Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 54. ACROBiosystems Recent Developments Table 55. Boster Bio Company Information Table 56. Boster Bio Business Overview Table 57. Boster Bio Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) & (US$ Million) Table 58. Boster Bio Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 59. Boster Bio Recent Developments Table 60. RayBiotech, Inc Company Information Table 61. RayBiotech, Inc Business Overview Table 62. RayBiotech, Inc Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) & (US$ Million) Table 63. RayBiotech, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 64. RayBiotech, Inc Recent Developments Table 65. Precision Medicine Group, LLC Company Information Table 66. Precision Medicine Group, LLC Business Overview Table 67. Precision Medicine Group, LLC Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) & (US$ Million) Table 68. Precision Medicine Group, LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 69. Precision Medicine Group, LLC Recent Developments Table 70. Bio-Techne Company Information Table 71. Bio-Techne Business Overview Table 72. Bio-Techne Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) & (US$ Million) Table 73. Bio-Techne Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 74. Bio-Techne Recent Developments Table 75. Cellular Technology Limited(immunospot) Company Information Table 76. Cellular Technology Limited(immunospot) Business Overview Table 77. Cellular Technology Limited(immunospot) Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) & (US$ Million) Table 78. Cellular Technology Limited(immunospot) Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 79. Cellular Technology Limited(immunospot) Recent Developments Table 80. Sino Biological, Inc Company Information Table 81. Sino Biological, Inc Business Overview Table 82. Sino Biological, Inc Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) & (US$ Million) Table 83. Sino Biological, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 84. Sino Biological, Inc Recent Developments Table 85. R&D Systems, Inc Company Information Table 86. R&D Systems, Inc Business Overview Table 87. R&D Systems, Inc Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) & (US$ Million) Table 88. R&D Systems, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 89. R&D Systems, Inc Recent Developments Table 90. ProteoGenix Company Information Table 91. ProteoGenix Business Overview Table 92. ProteoGenix Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) & (US$ Million) Table 93. ProteoGenix Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 94. ProteoGenix Recent Developments Table 95. Eve Technologies Company Information Table 96. Eve Technologies Business Overview Table 97. Eve Technologies Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) & (US$ Million) Table 98. Eve Technologies Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 99. Eve Technologies Recent Developments Table 100. NorthEast BioAnalytical Laboratories LLC Company Information Table 101. NorthEast BioAnalytical Laboratories LLC Business Overview Table 102. NorthEast BioAnalytical Laboratories LLC Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) & (US$ Million) Table 103. NorthEast BioAnalytical Laboratories LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 104. NorthEast BioAnalytical Laboratories LLC Recent Developments Table 105. mabtech Company Information Table 106. mabtech Business Overview Table 107. mabtech Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) & (US$ Million) Table 108. mabtech Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 109. mabtech Recent Developments Table 110. Pestka Biomedical Laboratories, Inc Company Information Table 111. Pestka Biomedical Laboratories, Inc Business Overview Table 112. Pestka Biomedical Laboratories, Inc Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) & (US$ Million) Table 113. Pestka Biomedical Laboratories, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 114. Pestka Biomedical Laboratories, Inc Recent Developments Table 115. Thermo Fisher Scientific Company Information Table 116. Thermo Fisher Scientific Business Overview Table 117. Thermo Fisher Scientific Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) & (US$ Million) Table 118. Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 119. Thermo Fisher Scientific Recent Developments Table 120. Antibodies Incorporated Company Information Table 121. Antibodies Incorporated Business Overview Table 122. Antibodies Incorporated Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) & (US$ Million) Table 123. Antibodies Incorporated Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 124. Antibodies Incorporated Recent Developments Table 125. Kaneka Eurogentec S.A Company Information Table 126. Kaneka Eurogentec S.A Business Overview Table 127. Kaneka Eurogentec S.A Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) & (US$ Million) Table 128. Kaneka Eurogentec S.A Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio Table 129. Kaneka Eurogentec S.A Recent Developments Table 130. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Image Figure 5. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Share by Type: 2025 VS 2032 Figure 7. Routine ELISA Assays Product Figure 8. Targeted Assay Development Product Figure 9. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Share by Application: 2025 VS 2032 Figure 11. Disease Diagnosis Product Figure 12. Vaccine Effectiveness Evaluation Product Figure 13. Drug Development Product Figure 14. Allergen Testing Product Figure 15. Others Product Figure 16. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 17. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Share by Region: 2025 VS 2032 Figure 19. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Share by Players in 2025 Figure 20. Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Manufacturers Established Date Figure 21. Global Top 5 and 10 Enzyme-Linked Immunosorbent Assay (ELISA) Service Players Market Share by Revenue in 2025 Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Share by Country (2021-2032) Figure 25. United States Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Canada Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Mexico Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Share by Country (2021-2032) Figure 28. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Share by Country (2021-2032) Figure 30. Germany Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. France Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. U.K. Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Italy Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Spain Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Russia Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Netherlands Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Nordic Countries Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Share by Country (2021-2032) Figure 40. China Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Japan Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. South Korea Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. India Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Share by Country (2021-2032) Figure 45. Australia Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. China Taiwan Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. Southeast Asia Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. South America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Share by Country (2021-2032) Figure 50. Brazil Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Argentina Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Chile Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Colombia Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Peru Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. Virology Research Services Ltd Revenue Growth Rate in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) Figure 56. ACROBiosystems Revenue Growth Rate in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) Figure 57. Boster Bio Revenue Growth Rate in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) Figure 58. RayBiotech, Inc Revenue Growth Rate in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) Figure 59. Precision Medicine Group, LLC Revenue Growth Rate in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) Figure 60. Bio-Techne Revenue Growth Rate in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) Figure 61. Cellular Technology Limited(immunospot) Revenue Growth Rate in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) Figure 62. Sino Biological, Inc Revenue Growth Rate in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) Figure 63. R&D Systems, Inc Revenue Growth Rate in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) Figure 64. ProteoGenix Revenue Growth Rate in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) Figure 65. Eve Technologies Revenue Growth Rate in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) Figure 66. NorthEast BioAnalytical Laboratories LLC Revenue Growth Rate in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) Figure 67. mabtech Revenue Growth Rate in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) Figure 68. Pestka Biomedical Laboratories, Inc Revenue Growth Rate in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) Figure 69. Thermo Fisher Scientific Revenue Growth Rate in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) Figure 70. Antibodies Incorporated Revenue Growth Rate in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026) Figure 71. Kaneka Eurogentec S.A Revenue Growth Rate in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026)

Scope & coverage.

Types
  • Routine ELISA Assays
  • Targeted Assay Development
Applications
  • Disease Diagnosis
  • Vaccine Effectiveness Evaluation
  • Drug Development
  • Allergen Testing
  • Others
Companies covered
  • Virology Research Services Ltd
  • ACROBiosystems
  • Boster Bio
  • RayBiotech, Inc
  • Precision Medicine Group, LLC
  • Bio-Techne
  • Cellular Technology Limited(immunospot)
  • Sino Biological, Inc
  • R&D Systems, Inc
  • ProteoGenix
  • Eve Technologies
  • NorthEast BioAnalytical Laboratories LLC
  • mabtech
  • Pestka Biomedical Laboratories, Inc
  • Thermo Fisher Scientific
  • Antibodies Incorporated
  • Kaneka Eurogentec S.A

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Enzyme-Linked Immunosorbent Assay (ELISA) Service by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Routine ELISA Assays
  5. 2.2.3 Targeted Assay Development
  6. 2.3 Enzyme-Linked Immunosorbent Assay (ELISA) Service by Application
  7. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  8. 2.3.2 Disease Diagnosis
  9. 2.3.3 Vaccine Effectiveness Evaluation
  10. 2.3.4 Drug Development
  11. 2.3.5 Allergen Testing
  12. 2.3.6 Others
  13. 2.4 Assumptions and Limitations
3 Enzyme-Linked Immunosorbent Assay (ELISA) Service Breakdown Data by Type
  1. 3.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Historic Market Size by Type (2021-2026)
  2. 3.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Forecasted Market Size by Type (2027-2032)
4 Enzyme-Linked Immunosorbent Assay (ELISA) Service Breakdown Data by Application
  1. 4.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Historic Market Size by Application (2021-2026)
  2. 4.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Perspective (2021-2032)
  2. 5.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Growth Trends by Region
  3. 5.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Enzyme-Linked Immunosorbent Assay (ELISA) Service Historic Market Size by Region (2021-2026)
  5. 5.2.3 Enzyme-Linked Immunosorbent Assay (ELISA) Service Forecasted Market Size by Region (2027-2032)
  6. 5.3 Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Dynamics
  7. 5.3.1 Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Trends
  8. 5.3.2 Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Drivers
  9. 5.3.3 Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Challenges
  10. 5.3.4 Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Enzyme-Linked Immunosorbent Assay (ELISA) Service Players by Revenue
  2. 6.1.1 Global Top Enzyme-Linked Immunosorbent Assay (ELISA) Service Players by Revenue (2021-2026)
  3. 6.1.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Enzyme-Linked Immunosorbent Assay (ELISA) Service Head Office and Area Served
  6. 6.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Players, Product Type & Application
  7. 6.5 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Manufacturers Established Date
  8. 6.6 Global Enzyme-Linked Immunosorbent Assay (ELISA) Service Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size (2021-2032)
  2. 7.2 North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Country (2021-2026)
  4. 7.4 North America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size (2021-2032)
  2. 8.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Country (2021-2026)
  4. 8.4 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size (2021-2032)
  2. 9.2 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size (2021-2032)
  2. 10.2 South America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Country (2021-2026)
  4. 10.4 South America Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size (2021-2032)
  2. 11.2 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Enzyme-Linked Immunosorbent Assay (ELISA) Service Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Virology Research Services Ltd
  2. 12.1.1 Virology Research Services Ltd Company Information
  3. 12.1.2 Virology Research Services Ltd Business Overview
  4. 12.1.3 Virology Research Services Ltd Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026)
  5. 12.1.4 Virology Research Services Ltd Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  6. 12.1.5 Virology Research Services Ltd Recent Developments
  7. 12.2 ACROBiosystems
  8. 12.2.1 ACROBiosystems Company Information
  9. 12.2.2 ACROBiosystems Business Overview
  10. 12.2.3 ACROBiosystems Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026)
  11. 12.2.4 ACROBiosystems Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  12. 12.2.5 ACROBiosystems Recent Developments
  13. 12.3 Boster Bio
  14. 12.3.1 Boster Bio Company Information
  15. 12.3.2 Boster Bio Business Overview
  16. 12.3.3 Boster Bio Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026)
  17. 12.3.4 Boster Bio Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  18. 12.3.5 Boster Bio Recent Developments
  19. 12.4 RayBiotech, Inc
  20. 12.4.1 RayBiotech, Inc Company Information
  21. 12.4.2 RayBiotech, Inc Business Overview
  22. 12.4.3 RayBiotech, Inc Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026)
  23. 12.4.4 RayBiotech, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  24. 12.4.5 RayBiotech, Inc Recent Developments
  25. 12.5 Precision Medicine Group, LLC
  26. 12.5.1 Precision Medicine Group, LLC Company Information
  27. 12.5.2 Precision Medicine Group, LLC Business Overview
  28. 12.5.3 Precision Medicine Group, LLC Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026)
  29. 12.5.4 Precision Medicine Group, LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  30. 12.5.5 Precision Medicine Group, LLC Recent Developments
  31. 12.6 Bio-Techne
  32. 12.6.1 Bio-Techne Company Information
  33. 12.6.2 Bio-Techne Business Overview
  34. 12.6.3 Bio-Techne Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026)
  35. 12.6.4 Bio-Techne Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  36. 12.6.5 Bio-Techne Recent Developments
  37. 12.7 Cellular Technology Limited(immunospot)
  38. 12.7.1 Cellular Technology Limited(immunospot) Company Information
  39. 12.7.2 Cellular Technology Limited(immunospot) Business Overview
  40. 12.7.3 Cellular Technology Limited(immunospot) Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026)
  41. 12.7.4 Cellular Technology Limited(immunospot) Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  42. 12.7.5 Cellular Technology Limited(immunospot) Recent Developments
  43. 12.8 Sino Biological, Inc
  44. 12.8.1 Sino Biological, Inc Company Information
  45. 12.8.2 Sino Biological, Inc Business Overview
  46. 12.8.3 Sino Biological, Inc Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026)
  47. 12.8.4 Sino Biological, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  48. 12.8.5 Sino Biological, Inc Recent Developments
  49. 12.9 R&D Systems, Inc
  50. 12.9.1 R&D Systems, Inc Company Information
  51. 12.9.2 R&D Systems, Inc Business Overview
  52. 12.9.3 R&D Systems, Inc Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026)
  53. 12.9.4 R&D Systems, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  54. 12.9.5 R&D Systems, Inc Recent Developments
  55. 12.10 ProteoGenix
  56. 12.10.1 ProteoGenix Company Information
  57. 12.10.2 ProteoGenix Business Overview
  58. 12.10.3 ProteoGenix Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026)
  59. 12.10.4 ProteoGenix Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  60. 12.10.5 ProteoGenix Recent Developments
  61. 12.11 Eve Technologies
  62. 12.11.1 Eve Technologies Company Information
  63. 12.11.2 Eve Technologies Business Overview
  64. 12.11.3 Eve Technologies Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026)
  65. 12.11.4 Eve Technologies Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  66. 12.11.5 Eve Technologies Recent Developments
  67. 12.12 NorthEast BioAnalytical Laboratories LLC
  68. 12.12.1 NorthEast BioAnalytical Laboratories LLC Company Information
  69. 12.12.2 NorthEast BioAnalytical Laboratories LLC Business Overview
  70. 12.12.3 NorthEast BioAnalytical Laboratories LLC Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026)
  71. 12.12.4 NorthEast BioAnalytical Laboratories LLC Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  72. 12.12.5 NorthEast BioAnalytical Laboratories LLC Recent Developments
  73. 12.13 mabtech
  74. 12.13.1 mabtech Company Information
  75. 12.13.2 mabtech Business Overview
  76. 12.13.3 mabtech Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026)
  77. 12.13.4 mabtech Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  78. 12.13.5 mabtech Recent Developments
  79. 12.14 Pestka Biomedical Laboratories, Inc
  80. 12.14.1 Pestka Biomedical Laboratories, Inc Company Information
  81. 12.14.2 Pestka Biomedical Laboratories, Inc Business Overview
  82. 12.14.3 Pestka Biomedical Laboratories, Inc Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026)
  83. 12.14.4 Pestka Biomedical Laboratories, Inc Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  84. 12.14.5 Pestka Biomedical Laboratories, Inc Recent Developments
  85. 12.15 Thermo Fisher Scientific
  86. 12.15.1 Thermo Fisher Scientific Company Information
  87. 12.15.2 Thermo Fisher Scientific Business Overview
  88. 12.15.3 Thermo Fisher Scientific Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026)
  89. 12.15.4 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  90. 12.15.5 Thermo Fisher Scientific Recent Developments
  91. 12.16 Antibodies Incorporated
  92. 12.16.1 Antibodies Incorporated Company Information
  93. 12.16.2 Antibodies Incorporated Business Overview
  94. 12.16.3 Antibodies Incorporated Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026)
  95. 12.16.4 Antibodies Incorporated Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  96. 12.16.5 Antibodies Incorporated Recent Developments
  97. 12.17 Kaneka Eurogentec S.A
  98. 12.17.1 Kaneka Eurogentec S.A Company Information
  99. 12.17.2 Kaneka Eurogentec S.A Business Overview
  100. 12.17.3 Kaneka Eurogentec S.A Revenue in Enzyme-Linked Immunosorbent Assay (ELISA) Service Business (2021-2026)
  101. 12.17.4 Kaneka Eurogentec S.A Enzyme-Linked Immunosorbent Assay (ELISA) Service Product Portfolio
  102. 12.17.5 Kaneka Eurogentec S.A Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research